<!DOCTYPE html><html lang="en"><head><title>Help for package nlmixr2data</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav class="package" aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {nlmixr2data}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#Bolus_1CPT'><p>1 Compartment Model Simulated Data from ACOP 2016</p></a></li>
<li><a href='#Bolus_1CPTMM'><p>1 Compartment Model w/ Michaelis-Menten Elimination</p></a></li>
<li><a href='#Bolus_2CPT'><p>2 Compartment Model</p></a></li>
<li><a href='#Bolus_2CPTMM'><p>2 Compartment Model with Michaelis-Menten Clearance</p></a></li>
<li><a href='#Infusion_1CPT'><p>1 Compartment Model Simulated Data from ACOP 2016</p></a></li>
<li><a href='#Infusion_1CPTMM'><p>1 Compartment Model w/MM elimination Simulated Data from ACOP 2016</p></a></li>
<li><a href='#Infusion_2CPT'><p>2 Compartment Model with Infusion Simulated Data from ACOP 2016</p></a></li>
<li><a href='#Infusion_2CPTMM'><p>2 Compartment Model w/MM elimination Simulated Data from ACOP 2016</p></a></li>
<li><a href='#invgaussian'><p>Inverse Guassian absorption model</p></a></li>
<li><a href='#mavoglurant'><p>Mavoglurant PK data</p></a></li>
<li><a href='#metabolite'><p>Parent/Metabolite dataset</p></a></li>
<li><a href='#nimoData'><p>Nimotuzumab PK data</p></a></li>
<li><a href='#nmtest'><p>One compartment test dataset showing NONMEM 7.4.3 output</p></a></li>
<li><a href='#Oral_1CPT'><p>1 Compartment Model with Oral Absorption Simulated Data from ACOP 2016</p></a></li>
<li><a href='#Oral_1CPTMM'><p>1 Compartment Model w/ Oral Absorption &amp; Michaelis-Menten Elimination</p></a></li>
<li><a href='#Oral_2CPT'><p>2 Compartment Model with Oral Absorption Simulated Data from ACOP 2016</p></a></li>
<li><a href='#Oral_2CPTMM'><p>1 Compartment Model w/ Oral Absorption &amp; Michaelis-Menten Elimination</p></a></li>
<li><a href='#pheno_sd'><p>Single Dose Phenobarbitol PK/PD</p></a></li>
<li><a href='#pump'><p>Pump failure example dataset</p></a></li>
<li><a href='#rats'><p>Pregnant Rat Diet Experiment</p></a></li>
<li><a href='#theo_md'><p>Multiple dose theophylline PK data</p></a></li>
<li><a href='#theo_sd'><p>Multiple dose theophylline PK data</p></a></li>
<li><a href='#Wang2007'><p>Simulated Data Set for comparing objective functions</p></a></li>
<li><a href='#warfarin'><p>Warfarin PK/PD data</p></a></li>
<li><a href='#wbcSim'><p>Simulated Friberg Myelosuppression model (Yuan Xiong)</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table role='presentation'>
<tr>
<td>Title:</td>
<td>Nonlinear Mixed Effects Models in Population PK/PD, Data</td>
</tr>
<tr>
<td>Version:</td>
<td>2.0.9</td>
</tr>
<tr>
<td>Description:</td>
<td>Datasets for 'nlmixr2' and 'rxode2'. 'nlmixr2' is used for fitting and comparing
    nonlinear mixed-effects models in differential
    equations with flexible dosing information commonly seen in pharmacokinetics
    and pharmacodynamics (Almquist, Leander, and Jirstrand 2015
    &lt;<a href="https://doi.org/10.1007%2Fs10928-015-9409-1">doi:10.1007/s10928-015-9409-1</a>&gt;). Differential equation solving is
    by compiled C code provided in the 'rxode2' package
    (Wang, Hallow, and James 2015 &lt;<a href="https://doi.org/10.1002%2Fpsp4.12052">doi:10.1002/psp4.12052</a>&gt;).</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-3">GPL (&ge; 3)</a></td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>RoxygenNote:</td>
<td>7.2.3</td>
</tr>
<tr>
<td>Depends:</td>
<td>R (&ge; 2.10)</td>
</tr>
<tr>
<td>LazyData:</td>
<td>true</td>
</tr>
<tr>
<td>BugReports:</td>
<td><a href="https://github.com/nlmixr2/nlmixr2data/issues/">https://github.com/nlmixr2/nlmixr2data/issues/</a></td>
</tr>
<tr>
<td>URL:</td>
<td><a href="https://nlmixr2.github.io/nlmixr2data/">https://nlmixr2.github.io/nlmixr2data/</a>,
<a href="https://github.com/nlmixr2/nlmixr2data/">https://github.com/nlmixr2/nlmixr2data/</a></td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2024-01-31 19:55:55 UTC; matt</td>
</tr>
<tr>
<td>Author:</td>
<td>Matthew Fidler <a href="https://orcid.org/0000-0001-8538-6691"><img alt="ORCID iD"  src="https://cloud.R-project.org/web/orcid.svg" style="width:16px; height:16px; margin-left:4px; margin-right:4px; vertical-align:middle" /></a>
    [aut, cre],
  Rik Schoemaker <a href="https://orcid.org/0000-0002-7538-3005"><img alt="ORCID iD"  src="https://cloud.R-project.org/web/orcid.svg" style="width:16px; height:16px; margin-left:4px; margin-right:4px; vertical-align:middle" /></a>
    [ctb],
  Kyle Baron [ctb],
  Thierry Wendling [ctb],
  Ted Grasella [ctb],
  C Weil [ctb],
  Yaning Wang [ctb],
  R O'Reilly [ctb],
  David D'Argenio [ctb],
  Rodriguez-Vera [ctb],
  D Gaver [ctb],
  Yuan Xiong [ctb],
  Wenping Wang [aut]</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Matthew Fidler &lt;matthew.fidler@gmail.com&gt;</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2024-01-31 20:40:02 UTC</td>
</tr>
</table>
<hr>
<h2 id='Bolus_1CPT'>1 Compartment Model Simulated Data from ACOP 2016</h2><span id='topic+Bolus_1CPT'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Bolus_1CPT
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>CL</dt><dd><p>Individual Clearance</p>
</dd>
<dt>SS</dt><dd><p>Steady State</p>
</dd>
<dt>II</dt><dd><p>Interdose Interval</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Bolus_1CPTMM'>1 Compartment Model w/ Michaelis-Menten Elimination</h2><span id='topic+Bolus_1CPTMM'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Bolus_1CPTMM
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>VM</dt><dd><p>Individual Vm constant</p>
</dd>
<dt>KM</dt><dd><p>Individual Km constant</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Bolus_2CPT'>2 Compartment Model</h2><span id='topic+Bolus_2CPT'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Bolus_2CPT
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 16 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V1</dt><dd><p>Individual Central Compartment Volume</p>
</dd>
<dt>CL</dt><dd><p>Individual Clearance</p>
</dd>
<dt>Q</dt><dd><p>Individual Between Compartment Clearance</p>
</dd>
<dt>V2</dt><dd><p>Periperial Volume</p>
</dd>
<dt>SS</dt><dd><p>Steady State Flag</p>
</dd>
<dt>II</dt><dd><p>Interdose interval</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment Indicator</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Bolus_2CPTMM'>2 Compartment Model with Michaelis-Menten Clearance</h2><span id='topic+Bolus_2CPTMM'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Bolus_2CPTMM
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 15 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V</dt><dd><p>Individual Central Compartment Volume</p>
</dd>
<dt>VM</dt><dd><p>Individual Vmax</p>
</dd>
<dt>KM</dt><dd><p>Individual Km</p>
</dd>
<dt>Q</dt><dd><p>Individual Q</p>
</dd>
<dt>V2</dt><dd><p>Individual Peripheral Compartment Volume</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment Indicator</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Infusion_1CPT'>1 Compartment Model Simulated Data from ACOP 2016</h2><span id='topic+Infusion_1CPT'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Infusion_1CPT
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>CL</dt><dd><p>Individual Clearance</p>
</dd>
<dt>SS</dt><dd><p>Steady State</p>
</dd>
<dt>II</dt><dd><p>Interdose Interval</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>RATE</dt><dd><p>NONMEM Rate</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Infusion_1CPTMM'>1 Compartment Model w/MM elimination Simulated Data from ACOP 2016</h2><span id='topic+Infusion_1CPTMM'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Infusion_1CPTMM
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>KM</dt><dd><p>Individual Km constant</p>
</dd>
<dt>VM</dt><dd><p>Individual Vm constant</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>RATE</dt><dd><p>NONMEM Rate</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Infusion_2CPT'>2 Compartment Model with Infusion Simulated Data from ACOP 2016</h2><span id='topic+Infusion_2CPT'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Infusion_2CPT
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 17 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>CL</dt><dd><p>Individual Clearance</p>
</dd>
<dt>Q</dt><dd><p>Individual Inter-compartmental Clearance</p>
</dd>
<dt>V2</dt><dd><p>Individual Peripheral Volume</p>
</dd>
<dt>SS</dt><dd><p>Steady State</p>
</dd>
<dt>RATE</dt><dd><p>NONMEM Rate</p>
</dd>
<dt>II</dt><dd><p>Interdose Interval</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Infusion_2CPTMM'>2 Compartment Model w/MM elimination Simulated Data from ACOP 2016</h2><span id='topic+Infusion_2CPTMM'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Infusion_2CPTMM
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>Q</dt><dd><p>Individual Between Compartment Clearance</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>V2</dt><dd><p>Individual Peripheral Volume</p>
</dd>
<dt>KM</dt><dd><p>Individual Km constant</p>
</dd>
<dt>VM</dt><dd><p>Individual Vm constant</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>RATE</dt><dd><p>NONMEM Rate</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='invgaussian'>Inverse Guassian absorption model</h2><span id='topic+invgaussian'></span>

<h3>Description</h3>

<p>Inverse Guassian absorption model
</p>


<h3>Usage</h3>

<pre><code class='language-R'>invgaussian
</code></pre>


<h3>Format</h3>

<p>A data frame with 32 rows and 6 columns
</p>

<dl>
<dt>time</dt><dd><p>Time of observation</p>
</dd>
<dt>cp</dt><dd><p>Concentration</p>
</dd>
</dl>



<h3>Source</h3>

<p>Figure 9.7 in D'Argenio DZ, Schumitzky A, and Wang X (2009). &quot;ADAPT
5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis
Software&quot;.
</p>

<hr>
<h2 id='mavoglurant'>Mavoglurant PK data</h2><span id='topic+mavoglurant'></span>

<h3>Description</h3>

<p>This was used in a full PBPK model. This one was published for mavoglurant
(Wendling et al. 2016).
</p>


<h3>Usage</h3>

<pre><code class='language-R'>mavoglurant
</code></pre>


<h3>Format</h3>

<p>A data frame with 2,678 rows by 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Subject ID</p>
</dd>
<dt>CMT</dt><dd><p>Compartment Number</p>
</dd>
<dt>EVID</dt><dd><p>Event ID</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV</p>
</dd>
<dt>DV</dt><dd><p>Dependent Variable, Mavoglurant</p>
</dd>
<dt>AMT</dt><dd><p>Dose Amount Keyword</p>
</dd>
<dt>TIME</dt><dd><p>Time (hr)</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>OCC</dt><dd><p>Occasion</p>
</dd>
<dt>RATE</dt><dd><p>Rate</p>
</dd>
<dt>AGE</dt><dd><p>Age</p>
</dd>
<dt>SEX</dt><dd><p>Sex</p>
</dd>
<dt>WT</dt><dd><p>Weight</p>
</dd>
<dt>HT</dt><dd><p>Height</p>
</dd>
</dl>



<h3>Source</h3>

<p>Wendling et al. 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='metabolite'>Parent/Metabolite dataset</h2><span id='topic+metabolite'></span>

<h3>Description</h3>

<p>Parent/Metabolite dataset
</p>


<h3>Usage</h3>

<pre><code class='language-R'>metabolite
</code></pre>


<h3>Format</h3>

<p>A data frame with 32 rows and 6 columns
</p>

<dl>
<dt>time</dt><dd><p>Time of observation</p>
</dd>
<dt>y1</dt><dd><p>Parent Concentration</p>
</dd>
<dt>y2</dt><dd><p>Metabolite Concentration</p>
</dd>
</dl>



<h3>Source</h3>

<p>D'Argenio DZ, Schumitzky A, and Wang X (2009). &quot;ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software&quot;.
</p>

<hr>
<h2 id='nimoData'>Nimotuzumab PK data</h2><span id='topic+nimoData'></span>

<h3>Description</h3>


<dl>
<dt>ID</dt><dd><p>Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Time (hrs)</p>
</dd>
<dt>AMT</dt><dd><p>Dose Amount Keyword</p>
</dd>
<dt>RATE</dt><dd><p>Rate</p>
</dd>
<dt>DV</dt><dd><p>Dependent Variable, Nimotuzumab</p>
</dd>
<dt>TAD</dt><dd><p>Time After Dose</p>
</dd>
<dt>CMT</dt><dd><p>Compartment Number</p>
</dd>
<dt>OCC</dt><dd><p>Occasion</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV</p>
</dd>
<dt>EVID</dt><dd><p>Event ID</p>
</dd>
<dt>WGT</dt><dd><p>Weight</p>
</dd>
<dt>BSA</dt><dd><p>Body Surface Area</p>
</dd>
<dt>AGE</dt><dd><p>Age</p>
</dd>
<dt>HGT</dt><dd><p>Height</p>
</dd>
<dt>DOS</dt><dd><p>Dose</p>
</dd>
</dl>



<h3>Usage</h3>

<pre><code class='language-R'>nimoData
</code></pre>


<h3>Format</h3>

<p>A data frame with 441 rows by 15 columns
</p>


<h3>Source</h3>

<p>Rodriguez-Vera et al. 2015
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='nmtest'>One compartment test dataset showing NONMEM 7.4.3 output</h2><span id='topic+nmtest'></span>

<h3>Description</h3>

<p>This is a example dataset originally created to show how similar
<code>mrgsolve</code> and NONMEM were (See ).
</p>


<h3>Usage</h3>

<pre><code class='language-R'>nmtest
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,157 rows and 15 columns
</p>

<dl>
<dt>id</dt><dd><p>NONMEM id</p>
</dd>
<dt>time</dt><dd><p>NONMEM time</p>
</dd>
<dt>cp</dt><dd><p>NONMEM cp output from 7.4.3</p>
</dd>
<dt>cmt</dt><dd><p>cmt specification 1=depot, 2=central</p>
</dd>
<dt>amt</dt><dd><p>Nonmem dose</p>
</dd>
<dt>evid</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>ii</dt><dd><p>Interdose Interval</p>
</dd>
<dt>ss</dt><dd><p>Steady state flag</p>
</dd>
<dt>addl</dt><dd><p>Individual Clearance</p>
</dd>
<dt>rate</dt><dd><p>Rate of the infusion</p>
</dd>
<dt>lagt</dt><dd><p>Lag time</p>
</dd>
<dt>bioav</dt><dd><p>Bioavailability</p>
</dd>
<dt>rat2</dt><dd><p>Modeled rate when <code>mode</code> == 1</p>
</dd>
<dt>dur2</dt><dd><p>Duration when <code>mode</code> == 2</p>
</dd>
<dt>mode</dt><dd><p>Mode = 0 is no modification, modeled rate when mode=1 and modeled duration when mode=2</p>
</dd>
</dl>



<h3>Details</h3>

<p>The original dataset was created by Kyle Baron and is composed of
<code>id&lt;100</code> the <code>id&gt;100</code> are modifications by Matthew Fidler to
benchmark steady state infusions with lag times and other uncommon
features.
</p>
<p>Note that <code>rxode2</code>/<code>nlmixr2</code> will not always match these behaviors
by default, we choose behaviors that we believe make sense.  There
are options to make <code>rxode2</code>/<code>nlmixr2</code> behave more like NONMEM.
However behaviors we believe are wrong we do not support.
</p>


<h3>Author(s)</h3>

<p>Kyle Baron &amp; Matthew Fidler
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Oral_1CPT'>1 Compartment Model with Oral Absorption Simulated Data from ACOP 2016</h2><span id='topic+Oral_1CPT'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Oral_1CPT
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 15 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>CL</dt><dd><p>Individual Clearance</p>
</dd>
<dt>KA</dt><dd><p>Individual Ka</p>
</dd>
<dt>SS</dt><dd><p>Steady State</p>
</dd>
<dt>II</dt><dd><p>Interdose Interval</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Oral_1CPTMM'>1 Compartment Model w/ Oral Absorption &amp; Michaelis-Menten Elimination</h2><span id='topic+Oral_1CPTMM'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Oral_1CPTMM
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>KA</dt><dd><p>Individual Absorption constant</p>
</dd>
<dt>V</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>VM</dt><dd><p>Individual Vm constant</p>
</dd>
<dt>KM</dt><dd><p>Individual Km constant</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Oral_2CPT'>2 Compartment Model with Oral Absorption Simulated Data from ACOP 2016</h2><span id='topic+Oral_2CPT'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Oral_2CPT
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 15 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>Q</dt><dd><p>Individual Inter-compartmental Clearance</p>
</dd>
<dt>V1</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>V2</dt><dd><p>Individual Simulated Peripheral Volume</p>
</dd>
<dt>CL</dt><dd><p>Individual Clearance</p>
</dd>
<dt>KA</dt><dd><p>Individual Ka</p>
</dd>
<dt>SS</dt><dd><p>Steady State</p>
</dd>
<dt>II</dt><dd><p>Interdose Interval</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Oral_2CPTMM'>1 Compartment Model w/ Oral Absorption &amp; Michaelis-Menten Elimination</h2><span id='topic+Oral_2CPTMM'></span>

<h3>Description</h3>

<p>This is a simulated dataset from the ACOP 2016 poster.  All
Datasets were simulated with the following methods.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Oral_2CPTMM
</code></pre>


<h3>Format</h3>

<p>A data frame with 7,920 rows and 14 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Simulated Time</p>
</dd>
<dt>DV</dt><dd><p>Simulated Dependent Variable</p>
</dd>
<dt>LNDV</dt><dd><p>Simulated log(Dependent Variable)</p>
</dd>
<dt>MDV</dt><dd><p>Missing DV data item</p>
</dd>
<dt>AMT</dt><dd><p>Dosing AMT</p>
</dd>
<dt>EVID</dt><dd><p>NONMEM Event ID</p>
</dd>
<dt>DOSE</dt><dd><p>Dose</p>
</dd>
<dt>KA</dt><dd><p>Individual Absorption constant</p>
</dd>
<dt>V1</dt><dd><p>Individual Simulated Volume</p>
</dd>
<dt>V2</dt><dd><p>Individual Simulated Perhipheral Volume</p>
</dd>
<dt>Q</dt><dd><p>Individual Inter-compartmental Clearance</p>
</dd>
<dt>VM</dt><dd><p>Individual Vm constant</p>
</dd>
<dt>KM</dt><dd><p>Individual Km constant</p>
</dd>
<dt>SD</dt><dd><p>Single Dose Flag</p>
</dd>
<dt>CMT</dt><dd><p>Compartment</p>
</dd>
</dl>



<h3>Details</h3>

<p>Richly sampled profiles were simulated for 4 different dose levels
(10, 30, 60 and 120 mg) of 30 subjects each as single dose (over
72h), multiple dose (4 daily doses), single and multiple dose
combined, and steady state dosing, for a range of test models: 1-
and 2-compartment disposition, with and without 1st order
absorption, with either linear or Michaelis-Menten (MM)
clearance(MM without steady state dosing). This provided a total
of 42 test cases. All inter-individual variabilities (IIVs) were
set at 30%, residual error at 20% and overlapping PK parameters
were the same for all models. A similar set of models was
previously used to compare NONMEM and Monolix4. Estimates of
population parameters, standard errors for fixed-effect
parameters, and run times were compared both for closed-form
solutions and using ODEs. Additionally, a sparse data estimation
situation was investigated where 500 datasets of 600 subjects each
(150 per dose) were generated consisting of 4 random time point
samples in 24 hours per subject, using a first-order absorption,
1-compartment disposition, linear elimination model.
</p>


<h3>Source</h3>

<p>Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W.
nlmixr2: an open-source package for pharmacometric modelling in
R. ACOP 2016
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='pheno_sd'>Single Dose Phenobarbitol PK/PD</h2><span id='topic+pheno_sd'></span>

<h3>Description</h3>

<p>This is from a PK study in neonatal infants.  They received
multiple doses of phenobarbital for seizure prevention.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>pheno_sd
</code></pre>


<h3>Format</h3>

<p>A data frame with 744 rows and 8 columns
</p>

<dl>
<dt>ID</dt><dd><p>Infant ID</p>
</dd>
<dt>TIME</dt><dd><p>Time (hr)</p>
</dd>
<dt>AMT</dt><dd><p>Dose (ug/kg)</p>
</dd>
<dt>WT</dt><dd><p>Weight (kg)</p>
</dd>
<dt>APGR</dt><dd><p>A 5-minute Apgar score to measure infant health</p>
</dd>
<dt>DV</dt><dd><p>The concentration of phenobarbitol in the serum (ug/mL)</p>
</dd>
<dt>MDV</dt><dd><p>If the dependent variable (DV) is missing; 0 for observations, 1 for doses</p>
</dd>
<dt>EVID</dt><dd><p>Event ID</p>
</dd>
</dl>



<h3>Details</h3>

<p>The data were originally given in Grasela and Donn(1985) and are
analyzed in Boeckmann, Sheiner and Beal (1994), in Davidian and
Giltinan (1995), and in Littell et al. (1996).
</p>


<h3>Source</h3>

<p>Pinheiro, J. C. and Bates, D. M. (2000), Mixed-Effects Models in S and S-PLUS, Springer, New York. (Appendix A.23)
</p>
<p>Davidian, M. and Giltinan, D. M. (1995), Nonlinear Models for
Repeated Measurement Data, Chapman and Hall, London. (section 6.6)
</p>
<p>Grasela and Donn (1985), Neonatal population pharmacokinetics of
phenobarbital derived from routine clinical data, Developmental
Pharmacology and Therapeutics, 8, 374-383.
</p>
<p>Boeckmann, A. J., Sheiner, L. B., and Beal, S. L. (1994), NONMEM
Users Guide: Part V, University of California, San Francisco.
</p>
<p>Littell, R. C., Milliken, G. A., Stroup, W. W. and Wolfinger,
R. D. (1996), SAS System for Mixed Models, SAS Institute, Cary,
NC.
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='pump'>Pump failure example dataset</h2><span id='topic+pump'></span>

<h3>Description</h3>

<p>The records the number of failures and operation time for groups
of 10 pumps.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>pump
</code></pre>


<h3>Format</h3>

<p>A data frame with 10 rows and 5 columns
</p>

<dl>
<dt>y</dt><dd><p>Number of pump failures</p>
</dd>
<dt>t</dt><dd><p>Failure Time</p>
</dd>
<dt>group</dt><dd><p>Continuous Operation (=1) or Intermittent Operation(=2)</p>
</dd>
<dt>ID</dt><dd><p>ID for group of 10 pumps</p>
</dd>
<dt>logtstd</dt><dd><p>Centered operation times</p>
</dd>
</dl>



<h3>Source</h3>

<p><a href="https://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#statug_nlmixed_sect040.htm">https://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#statug_nlmixed_sect040.htm</a>
</p>


<h3>References</h3>

<p>Gaver, D. P. and O'Muircheartaigh, I. G. (1987),
&quot;Robust Empirical Bayes Analysis of Event Rates,&quot;
Technometrics, 29, 1-15.
</p>

<hr>
<h2 id='rats'>Pregnant Rat Diet Experiment</h2><span id='topic+rats'></span>

<h3>Description</h3>

<p>16 pregnant rats have a control diet, and 16 have a chemically
treated diet.  The litter size for each rat is recorded after 4
and 21 days.  This dataset is used in the SAS Probit-model with
binomial data, and saved in the nlmixr2 package as rats.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>rats
</code></pre>


<h3>Format</h3>

<p>A data frame with 32 rows and 6 columns
</p>

<dl>
<dt>trt</dt><dd><p>Treatment; c= control diet; t=treated diet</p>
</dd>
<dt>m</dt><dd><p>Litter size after 4 days</p>
</dd>
<dt>x</dt><dd><p>Litter size after 21 days</p>
</dd>
<dt>x1</dt><dd><p>Indicator for trt=c</p>
</dd>
<dt>x2</dt><dd><p>Indicator for trt=t</p>
</dd>
<dt>ID</dt><dd><p>Rat ID</p>
</dd>
</dl>



<h3>Source</h3>

<p><a href="https://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#statug_nlmixed_sect040.htm">https://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#statug_nlmixed_sect040.htm</a>
</p>


<h3>References</h3>

<p>Weil, C.S., 1970. Selection of the valid number of
sampling units and a consideration of their combination in
toxicological studies involving reproduction, teratogenesis or
carcinogenesis. Fd. Cosmet. Toxicol. 8, 177-182.
</p>
<p>Williams, D.A., 1975. The analysis of binary responses
from toxicological experiments involving reproduction and
teratogenicity. Biometrics 31, 949-952.
</p>
<p>McCulloch, C. E. (1994),
&quot;Maximum Likelihood Variance Components Estimation for Binary Data,&quot;
Journal of the American Statistical Association, 89, 330 -
335.
</p>
<p>Ochi, Y. and Prentice, R. L. (1984),
&quot;Likelihood Inference in a Correlated Probit Regression Model,&quot;
Biometrika, 71, 531-543.
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='theo_md'>Multiple dose theophylline PK data</h2><span id='topic+theo_md'></span>

<h3>Description</h3>

<p>This data set starts with the day 1 concentrations of the
theophylline data that is included in the nlme/NONMEM. After day 7
concentrations were simulated with once a day regimen for 7 days
(QD).
</p>


<h3>Usage</h3>

<pre><code class='language-R'>theo_md
</code></pre>


<h3>Format</h3>

<p>A data frame with 348 rows by 7 columns
</p>

<dl>
<dt>ID</dt><dd><p>Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Time (hr)</p>
</dd>
<dt>DV</dt><dd><p>Dependent Variable, theophylline concentration (mg/L)</p>
</dd>
<dt>AMT</dt><dd><p>Dose Amount (kg)</p>
</dd>
<dt>EVID</dt><dd><p>rxode2/nlmixr2 event ID (not NONMEM event IDs)</p>
</dd>
<dt>CMT</dt><dd><p>Compartment number</p>
</dd>
<dt>WT</dt><dd><p>Body weight (kg)</p>
</dd>
</dl>



<h3>Source</h3>

<p>NONMEM/nlme
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='theo_sd'>Multiple dose theophylline PK data</h2><span id='topic+theo_sd'></span>

<h3>Description</h3>

<p>This data set is  the day 1 concentrations of the
theophylline data that is included in the nlme/NONMEM.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>theo_sd
</code></pre>


<h3>Format</h3>

<p>A data frame with 144 rows by 7 columns
</p>

<dl>
<dt>ID</dt><dd><p>Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Time (hr)</p>
</dd>
<dt>DV</dt><dd><p>Dependent Variable, theophylline concentration (mg/L)</p>
</dd>
<dt>AMT</dt><dd><p>Dose Amount (mg)</p>
</dd>
<dt>EVID</dt><dd><p>rxode2/nlmixr2 event ID (not NONMEM event IDs)</p>
</dd>
<dt>CMT</dt><dd><p>Compartment Number</p>
</dd>
<dt>WT</dt><dd><p>Body weight (kg)</p>
</dd>
</dl>



<h3>Source</h3>

<p>NONMEM/nlme
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='Wang2007'>Simulated Data Set for comparing objective functions</h2><span id='topic+Wang2007'></span>

<h3>Description</h3>

<p>This is a simulated dataset from Wang2007 where various NONMEM
estimation methods (Laplace FO, FOCE with and without
interaction) are described.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Wang2007
</code></pre>


<h3>Format</h3>

<p>A data frame with 20 rows and 3 columns
</p>

<dl>
<dt>ID</dt><dd><p>Simulated Subject ID</p>
</dd>
<dt>Time</dt><dd><p>Simulated Time</p>
</dd>
<dt>Y</dt><dd><p>Simulated Value</p>
</dd>
</dl>



<h3>Source</h3>

<p>Table 1 from Wang, Y <em>Derivation of Various NONMEM estimation methods</em>. J Pharmacokinet Pharmacodyn (2007) 34:575-593.
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='warfarin'>Warfarin PK/PD data</h2><span id='topic+warfarin'></span>

<h3>Description</h3>

<p>Warfarin PK/PD data
</p>


<h3>Usage</h3>

<pre><code class='language-R'>warfarin
</code></pre>


<h3>Format</h3>

<p>A data frame with 519 rows and 9 columns
</p>

<dl>
<dt>id</dt><dd><p>Patient identifier (n=32)</p>
</dd>
<dt>time</dt><dd><p>Time (h)</p>
</dd>
<dt>amt</dt><dd><p>Total drug administered (mg)</p>
</dd>
<dt>dv</dt><dd><p>Warfarin concentrations (mg/L) or PCA measurement</p>
</dd>
<dt>dvid</dt><dd><p>Dependent identifier Information (cp: Dose or PK, pca: PCA, factor)</p>
</dd>
<dt>evid</dt><dd><p>Event identifier</p>
</dd>
<dt>wt</dt><dd><p>Weight (kg)</p>
</dd>
<dt>age</dt><dd><p>Age (yr)</p>
</dd>
<dt>sex</dt><dd><p>Sex (male or female, factor)</p>
</dd>
</dl>



<h3>Source</h3>

<p>Funaki T, Holford N, Fujita S (2018). Population PKPD
analysis using nlmixr2 and NONMEM. PAGJA 2018
</p>


<h3>References</h3>

<p>O'Reilly RA, Aggeler PM, Leong LS. Studies of the coumarin
anticoagulant drugs: The pharmacodynamics of warfarin in man.
Journal of Clinical Investigation 1963; 42(10): 1542-1551
</p>
<p>O'Reilly RA, Aggeler PM. Studies on coumarin anticoagulant drugs
Initiation of warfarin therapy without a loading dose. Circulation
1968; 38: 169-177.
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+wbcSim">wbcSim</a></code>
</p>

<hr>
<h2 id='wbcSim'>Simulated Friberg Myelosuppression model (Yuan Xiong)</h2><span id='topic+wbcSim'></span>

<h3>Description</h3>


<dl>
<dt>ID</dt><dd><p>Subject ID</p>
</dd>
<dt>TIME</dt><dd><p>Time (hrs)</p>
</dd>
<dt>RATE</dt><dd><p>Rate</p>
</dd>
<dt>AMT</dt><dd><p>Dose Amount Keyword</p>
</dd>
<dt>DV</dt><dd><p>Dependent Variable, WBC</p>
</dd>
<dt>CMT</dt><dd><p>Compartment Number</p>
</dd>
<dt>V2I</dt><dd><p>Input Peripheral Volume</p>
</dd>
<dt>V1I</dt><dd><p>Input Central Volume</p>
</dd>
<dt>V1I</dt><dd><p>Input Clearance</p>
</dd>
<dt>EVID</dt><dd><p>nlmixr2/rxode2 classic evid</p>
</dd>
</dl>



<h3>Usage</h3>

<pre><code class='language-R'>wbcSim
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 280 rows and 10 columns.
</p>


<h3>Source</h3>

<p>Simulated Data for WBC pac ddmore model
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code><a href="#topic+Bolus_1CPTMM">Bolus_1CPTMM</a></code>,
<code><a href="#topic+Bolus_1CPT">Bolus_1CPT</a></code>,
<code><a href="#topic+Bolus_2CPTMM">Bolus_2CPTMM</a></code>,
<code><a href="#topic+Bolus_2CPT">Bolus_2CPT</a></code>,
<code><a href="#topic+Infusion_1CPTMM">Infusion_1CPTMM</a></code>,
<code><a href="#topic+Infusion_1CPT">Infusion_1CPT</a></code>,
<code><a href="#topic+Infusion_2CPTMM">Infusion_2CPTMM</a></code>,
<code><a href="#topic+Infusion_2CPT">Infusion_2CPT</a></code>,
<code><a href="#topic+Oral_1CPTMM">Oral_1CPTMM</a></code>,
<code><a href="#topic+Oral_1CPT">Oral_1CPT</a></code>,
<code><a href="#topic+Oral_2CPTMM">Oral_2CPTMM</a></code>,
<code><a href="#topic+Oral_2CPT">Oral_2CPT</a></code>,
<code><a href="#topic+Wang2007">Wang2007</a></code>,
<code><a href="#topic+mavoglurant">mavoglurant</a></code>,
<code><a href="#topic+nimoData">nimoData</a></code>,
<code><a href="#topic+nmtest">nmtest</a></code>,
<code><a href="#topic+pheno_sd">pheno_sd</a></code>,
<code><a href="#topic+rats">rats</a></code>,
<code><a href="#topic+theo_md">theo_md</a></code>,
<code><a href="#topic+theo_sd">theo_sd</a></code>,
<code><a href="#topic+warfarin">warfarin</a></code>
</p>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
